Blues Plans Sue CVS, Alleging It Overcharged for Generic Drugs

In a move that one attorney says may have a domino effect, Blue Cross Blue Shield plans recently filed suit against CVS Health Corp., claiming that the firm fraudulently overcharged them for generic drugs by “submitting claims for payment at artificially inflated prices.” CVS strongly denies the allegations.

The lawsuit, filed May 27 by Blues plans in Alabama, Florida, Minnesota, North Carolina, North Dakota and Kansas City, Mo., joins several others lodged against CVS and separately, against Walgreen Co., that allege the pharmacy chains failed to count prices in their generic cash discount programs when calculating “usual and customary” (U&C) prices for plan reimbursement.

© 2024 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

business-meeting
May 23

Plans Take Wait-and-See Approach to Vendors Promising Help with Weight Loss Medication Costs

READ MORE
iv-bag
May 23

Studies: IRA Will Spur Medicare Biosimilar Adoption — and Shift Costs to Part D Plans

READ MORE
rpm
May 23

Remote Physiologic Monitoring Use Among Medicaid Enrollees Skyrocketed From 2019 to 2021

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today